STAA

STAAR Surgical Company

STAA.US staar.com
22.66
-0.76 (-3.25%)
USD · NASDAQ
52-week range
15.59
35.87
Trading at 35% of the 52-week range
Market Cap
1.14B
P/E Ratio
283.25
Forward P/E
51.55
Book Value
7.29
Div. Yield
N/A
% Institutions
111.54%
% Insiders
0.854%

1 Year

-19.3%

3 Year

-49.5%

10 Year

+143.4%
Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Company Information

Company Name
STAAR Surgical Company
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
ISIN: US8523123052
CIK: 0000718937
CUSIP: 852312305
Currency: USD
Full Time Employees: 921
Phone: 626 303 7902
Website: staar.com
Fiscal Year End: December
IPO Date: Jul 15, 1983
Description:

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Address:

25510 Commercentre Drive, Lake Forest, CA, United States, 92630

People

Directors & Officers

Name Title Year Born
Mr. Warren Foust CEO, President & Director 1976
Ms. Deborah J. Andrews Executive VP & CFO 1957
Dr. Magda Michna Ph.D. Chief Development Officer NA
Dr. Ben Park Ph.D. Chief Technology Officer NA
Ms. Connie Johnson Director of Investor Relations NA
Ms. Kathleen Determann J.D. VP, Deputy General Counsel and Chief Compliance & Privacy Officer NA
Dr. Scott D. Barnes M.D. Chief Medical Officer 1963
Mr. Filip De Keersmaecker Chief Supply Chain & Quality Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 13, 2026 Broadwood Partners, L.P. N/A Purchase 316.02K $18.61 $5.88M
Mar 12, 2026 Broadwood Partners, L.P. N/A Purchase 299.43K $18.12 $5.43M
Mar 11, 2026 Broadwood Partners, L.P. N/A Purchase 54.76K $17.52 $959.47K
Jan 09, 2026 Broadwood Partners, L.P. N/A Purchase 27.49K $22.05 $606.04K
Jan 08, 2026 Broadwood Partners, L.P. N/A Purchase 3.24K $21.94 $71.09K
Jan 07, 2026 Broadwood Partners, L.P. N/A Purchase 66.47K $22.00 $1.46M
Jan 06, 2026 Broadwood Partners, L.P. N/A Purchase 336.95K $21.62 $7.28M
Nov 21, 2025 Broadwood Partners, L.P. N/A Purchase 797.49K $27.86 $22.22M
Nov 20, 2025 Broadwood Partners, L.P. N/A Purchase 393.38K $27.14 $10.68M
Nov 19, 2025 Broadwood Partners, L.P. N/A Purchase 309.13K $26.42 $8.17M

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BROADWOOD CAPITAL Inc 16.12M Jun 30, 2026 32.16% $24.18 0.00%
BlackRock Inc 6.67M Mar 31, 2026 13.29% $0.00 -9.43%
Yunqi Capital Ltd 3.26M Jun 30, 2026 6.50% $74.80 0.00%
Madison Avenue Partners, LP 2.44M Mar 31, 2026 4.87% $1.99 0.00%
Vanguard Portfolio Management, LLC 2.12M Mar 31, 2026 4.24% $0.00 0.00%
State Street Corp 1.83M Mar 31, 2026 3.66% $0.00 -5.54%
Vanguard Capital Management, LLC 1.69M Mar 31, 2026 3.37% $0.00 0.00%
Anatole Investment Management Ltd 1.65M Jun 30, 2026 3.29% $8.03 3.12%
Morgan Stanley - Brokerage Accounts 1.50M Mar 31, 2026 2.99% $0.00 61.41%
The Goldman Sachs Group Inc 1.07M Mar 31, 2026 2.13% $0.00 -48.48%
Two Seas Capital LP 1.04M Mar 31, 2026 2.07% $0.27 0.00%
Geode Capital Management, LLC 1.02M Mar 31, 2026 2.03% $0.00 -16.04%
Dimensional Fund Advisors, Inc. 867.14K Jun 30, 2026 1.73% $0.00 5.65%
American Capital Management Inc 846.66K Jun 30, 2026 1.69% $1.09 -3.57%
Point72 Asset Management, L.P. 823.15K Mar 31, 2026 1.64% $0.02 0.00%
AI-Squared Management Ltd 542.42K Jun 30, 2026 1.08% $8.30 102.33%
Jane Street Group LLC 442.18K Mar 31, 2026 0.88% $0.00 34.48%
Defender Capital, LLC. 431.19K Jun 30, 2026 0.86% $4.02 -33.10%
Charles Schwab Investment Management Inc 408.58K Mar 31, 2026 0.81% $0.00 -14.99%
Northern Trust Corp 400.22K Mar 31, 2026 0.80% $0.00 -16.04%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 3.03M 6.04% ▼ 0.34% Aug 31, 2026
2 Vanguard MStar Total Stk Mkt Idx Invest 949.46K 1.89% ▲ 0.00% Jul 31, 2026
3 iShares Russell 2000 ETF 870.30K 1.74% ▼ 0.57% Aug 31, 2026
4 Vanguard Small Cap Index 686.50K 1.37% ▲ 0.45% Jul 31, 2026
5 Vanguard Institutional Extnd Mkt Idx Tr 575.57K 1.15% ▲ 0.88% Jul 31, 2026
6 State Street SPDR Port S&P 600 Sm CpETF 467.38K 0.93% ▲ 0.00% Aug 31, 2026
7 Vanguard MStar Small Cap Growth Indx Inv 394.07K 0.79% ▲ 0.27% Jul 31, 2026
8 Fidelity Small Cap Index 368.37K 0.73% ▲ 7.25% Jun 30, 2026
9 Vanguard Tax-Managed Small Cap Adm 312.37K 0.62% ▲ 0.00% Jul 31, 2026
10 iShares Russell 2000 Growth ETF 287.11K 0.57% ▲ 0.00% Aug 31, 2026

Financial Highlights

Market Cap: $1.14B
EBITDA: $49.76M
P/E Ratio: $283.25
PEG Ratio: $0.76
Book Value: $7.29
Earnings/Share: $0.08
Profit Margin: 1.13%
Operating Margin: 10.89%
ROA (TTM): 5.65%
ROE (TTM): 1.09%
Revenue (TTM): $339.59M
Revenue/Share (TTM): $6.80
Earnings Growth (YOY): -10.50%
Revenue Growth (YOY): 111.00%

Valuation Metrics

Enterprise Value: $990.71M
Trailing P/E: 283.25
Forward P/E: 51.55

Shares Statistics

Shares Outstanding: 50.14M
Shares Float: 26.13M
% Insiders: 0.854%
% Institutions: 111.54%
Short % Float: 17.73%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$239.44M
Cost of Goods Sold
adjust
$-57.02M
Gross Profit
subtotal
$182.42M
SG&A
adjust
$-85.78M
R&D
adjust
$-40.06M
Other Operating Expense
adjust
$-102.53M
Operating Income
subtotal
$-45.95M
Other / Non-Operating Items
adjust
$-34.50M
Net Income
subtotal
$-80.45M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about STAA.US!